Pfizer wins Xeljanz label update; registers four new trials across RSV, eczema, sleep apneaSep 16Weekly roundup, 7 itemsabrocitinibberobenatide
Pfizer registers Phase 3 trials in alopecia areata and chronic migraine; two Phase 1 studies openJul 29Weekly roundup, 5 itemsBioNTech SEPF-08642534
Pfizer wins four Zithromax label updates in one week; two Phase 2 trial results also postedJul 15Weekly roundup, 6 itemsatirmociclibazithromycin
Pfizer wins five FDA label updates for tofacitinib, ritlecitinib, abrocitinib; Crohn's trial haltedJul 2Weekly roundup, 12 itemsabrocitinibatirmociclib
Sign inSign in